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Adherens junctions are multiprotein complexes medi-
ating cell-cell adhesion and communication. They are
organized around a transmembrane cadherin, which
binds a set of cytoplasmic proteins required for adhe-
sion and to link the complex to the actin cytoskeleton.
Three components of Drosophila adherens junctions,
analogous to those in vertebrates, have been identified:
Armadillo (homolog of b-catenin), Drosophila E-cad-
herin (DE-cadherin), and a-catenin. We carried out the
first analysis of the interactions between these proteins
using in vitro binding assays, the yeast two-hybrid sys-
tem, and in vivo assays. We identified a 76-amino acid
region of Armadillo that is necessary and sufficient for
binding a-catenin and found that the N-terminal 258
amino acids of a-catenin interact with Armadillo. A
large region of Armadillo, spanning six central Arma-
dillo repeats, is required for DE-cadherin binding,
whereas only 41 amino acids of the DE-cadherin cyto-
plasmic tail are sufficient for Armadillo binding. Our
data complement and extend results obtained in studies
of vertebrate adherens junctions, providing a founda-
tion for understanding how junctional proteins assem-
ble and a basis for interpreting existing mutations and
creating new ones.
Cell-cell adhesion and communication are required for cells
to form organized tissues. One structure used by cells for these
purposes is the adherens junction, found near the apical sur-
face of epithelial cells and found also in other cell types. Adhe-
rens junctions mediate calcium-dependent cell-cell adhesion
and anchor the actin cytoskeleton (reviewed in Ref. 1). In
addition, many signaling molecules are localized to adherens
junctions, suggesting a role in the transmission of intercellular
signals (reviewed in Ref. 2).
Adherens junctions consist of transmembrane cadherins and
a set of cytoplasmic proteins associated with cadherin cytoplas-
mic domains (reviewed in Refs. 1 and 3). The extracellular
domains of cadherins interact homotypically with cadherins of
neighboring cells. The cytoplasmic proteins a-catenin, b-cate-
nin, and plakoglobin (or g-catenin) are required for cadherin
adhesive function and anchor the actin cytoskeleton. The Src
tyrosine kinase substrate p120cas is also present in adherens
junctions (4, 5); its function remains unknown. Changes in
tyrosine phosphorylation of b-catenin (reviewed in Ref. 2) and
p120cas (6) correlate with transformation and associated
changes in cell adhesion.
To understand the cell biological function of adherens junc-
tions, we must determine how interactions among different
adherens junction proteins mediate assembly. b-Catenin and
plakoglobin bind directly to the E-cadherin cytoplasmic domain
in a mutually exclusive fashion (7, 8). b-Catenin and plakoglo-
bin are 70% identical in amino acid sequence; their central
regions, containing ;13 copies of the 42-amino acid Arm1 re-
peat (9), are particularly well conserved (;80% amino acid
identity). These highly conserved Arm repeats mediate inter-
action with cadherin (10–12), suggesting that b-catenin and
plakoglobin compete for the same binding site. The N-terminal
regions of both b-catenin and plakoglobin bind to a-catenin;
a-catenin does not bind cadherin directly (11, 13–15). a-Cate-
nin, in turn, links adherens junctions to actin, directly (16) or
via a-actinin (17). p120cas also binds directly to E-cadherin (18),
but likely to a site distinct from that bound by b-catenin/
plakoglobin (4, 5). p120cas does not interact with a-catenin (18),
however, and thus does not appear to mediate interaction with
actin. The core cadherin-catenin complex forms higher order
assemblies such as the zonula adherens. Both E- and N-cad-
herins dimerize (19, 20), and association with the cytoskeleton
may help form larger assemblies.
Adherens junctions were first described in vertebrates, but
precisely analogous structures exist in Drosophila. The Dro-
sophila homolog of b-catenin is Armadillo, first discovered be-
cause of its role in transducing the Wingless cell-cell signal
(reviewed in Ref. 3). Arm is structurally similar to b-catenin
and plakoglobin (it is 73% identical to b-catenin), with 13 Arm
repeats (9) flanked by N- and C-terminal regions. Drosophila
homologs of E-cadherin (DE-cadherin) and a-catenin have been
identified (21, 22); no direct homolog of plakoglobin has been
found. Both Arm and DE-cadherin are required for proper
cell-cell adhesion in vivo (23–26).
We undertook a systematic study of the interactions between
Drosophila Arm and its adherens junction partners, DE-cad-
herin and a-catenin. We localized binding sites for each of these
proteins on Arm using in vitro binding assays, the yeast two-
hybrid system, and in vivo binding assays. We also identified
regions of a-catenin and DE-cadherin required for Arm bind-
ing. These experiments complement and extend analysis of the
vertebrate homologs of Arm. Our parallel in vivo studies con-
firm the importance of these interactions for adherens junction
function (27).
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EXPERIMENTAL PROCEDURES
Plasmid Constructions
Further details are available upon request.
GST-Arm Fusions—Arm fragments were PCR-amplified from E9
cDNA (28) with Vent DNA polymerase in 10 cycles. 59-Primers contain
a BamHI site and a methionine codon; 39-primers contain EcoRI and
BamHI sites and a stop codon (Tables I and II show end points of the
constructs). PCR products were subcloned into both pBluescript KS1
and pLM1; pLM1 was generated by inserting oligomers creating BglII
and EcoRI sites in the appropriate reading frame of pGEX2T128/129
(gift of Dr. M. Blanar (29)). The vector/insert junctions were sequenced;
many inserts were entirely sequenced. pLM1-N1 and pLM1-N5 were
generated by cloning BamHI/partial BclI digestion products of the arm
E9 cDNA into the BglII site of pLM1.
PCR-mediated Site-directed Mutagenesis—Mutagenesis was per-
formed as described (30) using pBS-N2 as a template. The fragments
from the second PCR were digested with BamHI and subcloned into the
pLM1 BglII site. Mutants were screened for fusion protein expression
and confirmed by sequencing.
GST-a-Catenin Fusions—The C-terminal two-thirds of a-catenin
was subcloned from pBS-a-catenin (21) as a BglII/XbaI fragment, which
was ligated with BglII/EcoRI-digested pLM1, followed by filling with
Klenow fragment and a second ligation, creating pLM1-aC. The N-
terminal end of a-catenin was made by PCR with Vent polymerase in 10
cycles. The 59-primer contains BglII, EcoRI, and EcoRV sites, while the
39-primer is just 39 to a BglII site in a-catenin. The PCR product was cut
with BglII and cloned into pLM1-aC, creating pLM1-a-catenin. pLM1-
a-catRI was generated by eliminating the C-terminal half of a-catenin
by EcoRI digestion.
Two-hybrid Plasmids—pCK2 and pCK4 were generated from
pBTM116 (gift of P. Bartel and S. Fields) and pACT2 (gift of S. Elledge),
respectively, by inserting oligomers creating BamHI and EcoRI sites in
the desired reading frame. Arm fragments generated by PCR as de-
scribed above were cloned into pCK2 and pCK4 as BamHI/EcoRI or
BamHI fragments. Mutant Arm fragments were generated by PCRwith
full-length Arm mutant constructs (27) as templates. The a-catenin N
terminus was isolated from pLM1-a-catenin by BglII digestion and
cloned into the BamHI site of pCK2 and pCK4. The cytoplasmic domain
of DE-cadherin and fragments thereof were amplified by PCR (with
primers containing BamHI and EcoRI sites), digested with BamHI and
EcoRI, and cloned into pCK4 (see Fig. 11A).
Expression and Purification of GST Fusion Proteins and Bead
and Blot Binding Assays
Fusion proteins were expressed in Escherichia coli DH5a. Overnight
cultures were diluted 1:10, grown for 1 h, and induced with 0.5 mM
isopropyl-1-thio-b-D-galactopyranoside. After 2 h of further growth,
cells were lysed in MTPBS (150 mM NaCl, 16 mM Na2HPO4, and 4 mM
NaH2PO4) by sonication (20% output) twice for 30 s. 1% Tween 20 and
1% Triton X-100 were added to lysates, and cell debris was pelleted at
6000 rpm for 10 min. Glutathione-conjugated agarose beads were
added, incubated for 30 min at room temperature, and then washed
with MTPBS plus 0.1% Triton X-100 and 1% Tween 20. Wild-type
Drosophila extracts were made from 0–20-h-old embryos. Embryos
were rinsed with 0.1% Triton X-100, dechorionated in 50% bleach for 4
min, rinsed again, and then ground in RIPA buffer (23) or NET (400 mM
NaCl, 5 mM EDTA, 50 mM Tris, pH 7.5, and 1% Nonidet P-40), both with
50 mg/ml phenylmethylsulfonyl fluoride, 1 mg/ml leupeptin, 1.4 mg/ml
pepstatin, 50 mM NaF, and 1 mM NaVO3. For bead binding assays,
fusion protein bound to glutathione-agarose was mixed with wild-type
embryo extract in RIPA buffer or NET at room temperature on a
nutator for 2 h, and beads were washed with excess buffer four times for
a total of 20 min. Samples were boiled for 5 min in SDS sample buffer
and analyzed by SDS-PAGE and immunoblotting. For blot binding
assays, fusion proteins were purified on glutathione-agarose, separated
by SDS-PAGE, and transferred to nitrocellulose. Blots were stained
with Ponceau S to detect total protein and incubated with wild-type
embryo extract in RIPA buffer at room temperature for 2 h, followed by
washing with excess RIPA buffer five times for a total of 1 h. Blots were
immunoblotted with anti-a-catenin antibody and visualized by en-
hanced chemiluminescence (Amersham Corp.).
Fly Stocks and ConA-Sepharose Fractionation
Wild-type flies were Canton S; armH8.6, armXM19, armXP33, and arm#2
are described in Ref. 31. armDN was generated as a germ line transfor-
mant by injection into y w flies. To create pUAST-3armRC, a fragment
of Arm containing the repeats and the C terminus (amino acids 128–
843) was excised from pLM1-RC with BamHI and EcoRI and ligated
into pUAST-3 (a modified version of pUAST (32) with the EcoRI and
BamHI sites inverted in the polylinker). ConA-Sepharose fractionation
was done as described (23), but using NET instead of RIPA buffer.
Two-hybrid System
We used a version (33) of the yeast two-hybrid system (34) in which
one protein is fused to the DNA-binding domain of E. coli LexA and its
putative partner is fused to the transcriptional activation domain of
yeast Gal4p. Interaction of the partners activates two reporter genes,
lacZ, whose product can be quantitated, andHIS3. The yeast strain L40
(MATa his3D200 trp1–901 leu2–3,112 ade2 LYS2::(lexAop)4-HIS3
URA3::(lexAop)8-lacZ) (33) was used for all experiments. The strain was
transformed (35) simultaneously with two plasmids encoding different
fusion proteins (in pCK2 and pCK4); transformants were selected on
synthetic complete medium lacking tryptophan and leucine. HIS3 ac-
tivation was assayed by spotting dilutions of saturated liquid cultures
onto synthetic complete medium lacking tryptophan, leucine, and his-
tidine and containing 25 mM 3-aminotriazole; growth was compared
with that of colonies on medium lacking only tryptophan and leucine. In
all cases, HIS3 activation paralleled lacZ activation (data not shown).
FIG. 1. Arm is a modular protein that can be divided into three
regions.
TABLE I
Diagram of portions of Arm tested for association with a-catenin either as GST-Arm fusion proteins or in the two-hybrid system.
Corresponding amino acid positions are indicated on the right. Binding activity is shown as plus and minus symbols. N.D., not determined.
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Liquid b-galactosidase assays were performed as described (36). Cells
from 3 ml of late log phase culture were washed and resuspended in 1
ml of Z buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM
MgSO4, and 40 mM 2-mercaptoethanol). 200-ml aliquots of this suspen-
sion were mixed with 600 ml of Z buffer, 20 ml of 0.1% SDS, and 3 drops
of chloroform. Samples were vortexed for 15 s and incubated at 28 °C for
10–15 min. Reactions were initiated by adding 160 ml of 4 mg/ml
o-nitrophenyl-b-D-galactopyranoside (in Z buffer) and stopped when the
solution reached an appropriate yellow color (A420 ; 0.4–0.7) by adding
400 ml of 1 M Na2CO3. b-Galactosidase activity (in Miller units) was
calculated as follows: A420 3 1000 divided by (the A600 of the initial cell
suspension 3 the volume of suspension used (0.2 ml) 3 the time in
minutes of color development). All values shown are averages from
assays in duplicate or triplicate on cultures of at least six independent
transformants. Protein extracts for immunoblotting were made from
samples of cultures grown for b-galactosidase assays. Cells from 1.5 ml
of culture were resuspended in 50 ml of 2 3 Laemmli buffer, frozen at
270 °C, and boiled for 5 min. Immunoblotting was performed using
anti-LexA antibody (a gift of Dr. E. Golemis) at 1:5000.
RESULTS
The a-Catenin-binding Site on Armadillo Is at the Junction
of the N Terminus and the Repeats—To decipher the biochem-
ical roles of Arm in adherens junctions, we set out to charac-
terize the regions of Arm to which its adherens junction part-
ners, a-catenin and DE-cadherin, bind. We simultaneously
took three approaches: in vivo in Drosophila embryos (Ref. 27;
see data below), in vitro binding assays, and the yeast two-
hybrid system. These approaches were chosen to complement
one another, minimizing problems caused by the limitations of
each assay.
Arm protein can be divided into three regions (Fig. 1). The
central two-thirds of Arm is composed of 13 copies of an imper-
fect ;42-amino acid repeat, the Arm repeat, with non-repeat
amino acids between Arm repeats 10 and 11 (9, 28). There are
also regions N- and C-terminal to the repeats. For in vitro
binding experiments, different parts of Arm were expressed in
E. coli as GST fusion proteins. Many fusion proteins were
generated and tested for their ability to bind a-catenin in two
different assays. These assays localized the a-catenin-binding
site to the junction of the N terminus and the Arm repeats
(Table I).
The first assay used to detect interaction was a bead binding
assay, in which purified GST-Arm fusion proteins bound to
glutathione-agarose beads (37) were used to recover interacting
proteins from wild-type embryo extract. a-Catenin binding was
assayed by immunoblotting with anti-a-catenin antibody (21).
Neither the Arm repeats nor the C terminus contains strong
a-catenin-binding sites (Fig. 2A, upper panel). The smallest
region retaining full binding activity is a 76-amino acid region
(fusion protein N4, amino acids 90–165) extending from the
N-terminal region into Arm repeat 1. The second assay used
was a blot binding (far-Western) assay, in which GST-Arm
fusion proteins immobilized on nitrocellulose were incubated
with wild-type embryo extract (Fig. 3). This assay confirmed
that the 76-amino acid region is sufficient for binding and also
implied that much of the sequence is necessary; removal of the
C-terminal 17 amino acids of this minimal fragment (GST-Arm
fusion protein N5) or removal of 23 amino acids from its N
terminus (fusion protein N6) eliminates a-catenin binding in
this assay (Fig. 3). These results are summarized in Table I.
Similar data were obtained with the yeast two-hybrid system
(33, 34). We generated constructs with boundaries identical to
those used in the in vitro assays. As in those assays, a 76-amino
acid fragment at the junction of the N terminus and the Arm
repeats of Arm (amino acids 90–165) interacts with a-catenin
(Fig. 4, A and B). In this assay, the C-terminal 17 amino acids
of this region are not essential for a-catenin interaction (fusion
protein N5). We also detected a very weak a-catenin interaction
when 23 amino acids were removed from the N terminus of this
region (fusion protein N6). Other fragments of Arm, such as the
entire repeat region, do not interact with a-catenin (Fig. 4C).
We also mapped the in vivo a-catenin-binding site. We gen-
erated a mutant, armS14, with a 39-amino acid deletion in the
N terminus (removing amino acids 101–139); these amino acids
are within the 76-amino acid region required for a-catenin
binding in vitro. This mutation was reintroduced into flies and
abolishes the ability of Arm to bind to a-catenin in vivo (27). In
contrast, the most N-terminal portion of Arm is not required for
a-catenin binding in vivo. We generated and reintroduced in
vivo a second mutant, armS10, with a 54-amino acid deletion in
the N terminus (removing amino acids 34–87); this deletion
falls outside the region defined as essential for binding in vitro.
This mutant protein was tagged with a c-Myc epitope to dis-
tinguish it from wild-type endogenous Armadillo. Mutant pro-
tein can be specifically immunoprecipitated with anti-c-Myc
antibody; a-catenin co-immunoprecipitates with this mutant
protein (Fig. 5A).
Point Mutations inside the 76-Amino Acid Region Abolish
a-Catenin Binding Activity—The 76-amino acid region suffi-
cient for binding a-catenin in vitro is highly conserved between
Arm and its vertebrate relatives b-catenin (39) and plakoglobin
FIG. 2. The a-catenin-binding site on Arm is at the junction of
the N terminus and the repeats. A, GST-Arm fusion proteins bound
to glutathione-agarose beads were incubated with wild-type Drosophila
embryo extract in RIPA buffer. Bound proteins were analyzed by SDS-
PAGE and immunoblotting with anti-a-catenin antibody (Anti a-cat;
upper panel). The same blot was reprobed with anti-BicD antibody to
control for nonspecific retention of extract (lower panel); BicD is a
nonjunctional cytoplasmic protein (38). Total embryo extract from wild-
type embryos (Canton S (CS)) was used as a positive control. The fusion
proteins indicated are diagramed in Table I.N1 indicates N terminus 1,
etc., while GST indicates GST alone. Molecular weight markers are
indicated on the left. B, the same blot was stained with Ponceau S to
visualize the amount of fusion protein used in each reaction. Full-length
fusion proteins are indicated with arrowheads. R1C, fragment of Arm
containing the repeats and the C terminus; C, C terminus; MMW,
medium molecular weight markers.
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(40); b-catenin and Arm are 79% identical in this region, while
Arm and plakoglobin are 51% identical. To determine whether
the entire region or only a subset was required for binding, we
generated point mutations using PCR mutagenesis, based on
the hypothesis that clustered charged residues would probably
be on the surface of the protein. We made seven different
mutants with clustered point mutations within fusion protein
N2, which has a-catenin binding activity. In the first set of
mutants, two to four positively charged amino acids that are
conserved among Arm, b-catenin, and plakoglobin were
changed to alanines (Fig. 6A). a-Catenin binding activity is
abolished in each mutant (Fig. 6B). We also made point muta-
tions in nonconserved residues, replacing Arm residues either
with corresponding b-catenin residues or with alanines (Fig.
6A). Both alanine substitution mutants greatly reduced a-cate-
nin binding activity. Putting b-catenin residues at the center of
the 76-amino acid region reduced binding, while b-catenin res-
idue substitutions at the N-terminal end of the binding region
did not alter binding (Fig. 6B).
The Binding Site for Armadillo on a-Catenin Is in the N-
terminal 258 Amino Acids—We generated a full-length GST-
a-catenin fusion protein and used it in both bead and blot
binding assays. Full-length a-catenin bound Arm in a blot
binding assay (Fig. 7 and data not shown), as did proteolytic
breakdown products with molecular masses of .25 kDa (data
not shown). A smaller GST fusion protein containing the N-
terminal half of a-catenin (amino acids 1–526) binds to Arm as
well as full-length a-catenin (Fig. 7). We extended these data
using the two-hybrid system; in this assay, the N-terminal 258
amino acids of a-catenin bind Arm (100-fold better than the
vector control) (Fig. 4).
The in Vivo DE-cadherin-binding Site on Armadillo Maps to
the Central Repeat Region—Most of the original in vivo arm
mutations truncate the coding sequence, yielding a series of
C-terminally truncated mutant proteins (31). We examined the
ability of some of these mutant Arm proteins to associate with
DE-cadherin in vivo. We also assayed a protein lacking the
entire N terminus. We used binding to ConA-Sepharose to
measure association with DE-cadherin. Cadherins are glyco-
proteins that are recognized by this lectin (41); since wild-type
Arm associates with DE-cadherin, a fraction of Arm binds to
ConA (23). If a mutant protein forms a complex with DE-
cadherin, it will bind to ConA-Sepharose and thus be included
in the bound fraction. In contrast, mutant protein that cannot
form a complex will be exclusively in the unbound fraction.
ArmDN, which lacks the entire N-terminal domain, binds DE-
cadherin in vivo (Fig. 5B). armH8.6 mutant protein, lacking
virtually the entire C-terminal domain, also binds DE-cadherin
(Fig. 5, C and D). Proteins encoded by armXM19, armXP33, and
arm#2, with truncations in repeats 13, 10, and 9, respectively,
also retain some binding activity (Fig. 5, C and D). Hence, the
in vivo DE-cadherin-binding site on Arm lies at least in part
between Arm repeats 1–9.
FIG. 3. A 76-amino acid region of Arm is responsible for asso-
ciation with a-catenin. Fusion proteins (diagramed in Table I) were
separated by SDS-PAGE and transferred to nitrocellulose, which was
stained with Ponceau S to detect the total protein present (right panel),
and then incubated with wild-type embryo extract. The blot was then
immunoblotted with anti-a-catenin antibody (left panel). Full-length
fusion proteins are indicated with arrowheads. Note that only full-
length N-terminal fusion proteins bind to a-catenin; C-terminally trun-
cated proteins (generated during purification or in bacteria) fail to bind.
Molecular weight markers are shown on the left. HMW, high molecular
weight markers; MMW, medium molecular weight markers; R1–13,
Arm repeats 1–13; C, C terminus.
FIG. 4. The N-terminal region of Arm binds to a-catenin,
whereas the repeat region binds to DE-cadherin. A, N-terminal
fragments of Arm (see Table I) were fused to the Gal4p activation
domain and assayed for interaction with a LexA fusion protein contain-
ing the N-terminal 258 amino acids of a-catenin (a-cat) by measuring
b-galactosidase activity from the lacZ reporter gene. Values are in
Miller units. 0 indicates a plasmid containing only the Gal4p activation
domain. B, fragments N4 and N6 fused to LexA (and a plasmid encoding
only LexA (0)) were assayed in combination with pCK4, which encodes
the Gal4p activation domain alone, or pCK4-a-catenin, which encodes a
fusion of the 258 N-terminal amino acids of a-catenin to Gal4p. (Note
that N1 and N5 fused to LexA give strong transcriptional activation;
these fragments were therefore assayed only in the target vector.) C,
the 76-amino acid N4 fragment or the entire Arm repeat region (R1–13)
was fused to LexA (in pCK2; 0 indicates a control with no insertion) and
assayed for interaction in the two-hybrid system with the N-terminal
258 amino acids of a-catenin (a-cat) or the cytoplasmic domain of
DE-cadherin (DEC) fused to the Gal4p activation domain in pCK4.
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The Central-most Arm Repeats Are Required for Binding to
DE-cadherin in Vitro and in Yeast—To further narrow down
the region of Arm interacting with DE-cadherin in vitro, we
used GST-Arm fusion proteins containing portions of the Arm
repeat region. Both full-length Arm and a fragment containing
repeats 1–13 bind strongly to DE-cadherin. Repeats 3–10 and
repeats 3–8 retain DE-cadherin binding activity, while the
smaller fragment containing repeats 5 and 6 does not bind
(Fig. 8).
Regions of Arm were also tested for interaction with DE-
cadherin in the two-hybrid system. The N-terminal region of
Arm does not interact with the cytoplasmic domain of DE-
cadherin (Fig. 4C), but parts of the repeat region do (Fig. 9 and
Table II). The smallest fragment of Arm capable of binding
DE-cadherin is one containing Arm repeats 3–8 (R3–8).
Smaller fragments (containing repeats 3–7 or 4–8) do not
interact with cadherin, but repeats 4–13 and repeats 1–7 show
substantial interaction; repeats 1–6 bind less well. (All LexA-
Arm fusion proteins that do not interact with DE-cadherin are
expressed in yeast to at least the same level as repeats 1–13, as
assayed by Western blotting (data not shown).) We found a
similar pattern of interactions between Arm and a vertebrate
cadherin (mouse OB-cadherin; a gift of Dr. P. McCrea), except
that the vertebrate cadherin shows reduced binding to repeats
1–7 (Fig. 9 and Table II).
We examined the effect of mutations in the Arm repeat
region on the interaction with DE-cadherin both in yeast and in
vivo. Five mutations (diagramed in Fig. 10A) were introduced
into the full-length repeat region (repeats 1–13); three were
also introduced into the smallest interacting fragment of Arm
(repeats 3–8). These mutations (in the context of full-length
Arm protein) were also tested in vivo (27): mutating repeat 1 or
fusing repeats 10 and 11 did not affect DE-cadherin co-immu-
noprecipitation; removing repeat 5 or 8 greatly reduced cad-
herin binding; and removing repeats 3–6 eliminated cadherin
binding in vivo. In the two-hybrid system, we observed similar
but weaker effects (Fig. 10B). Mutating repeat 1 or fusing
repeats 10 and 11 does not affect the interaction with cadherin,
but removing repeats 3–6 eliminates binding. Removing repeat
5 (from repeats 1–13) does not substantially alter DE-cadherin
binding, in contrast to the result in vivo; the high level of
expression of the fusion protein in yeast may compensate for
reduced binding affinity. We were not able to assess the effect
of removing repeat 8 (from repeats 1–13) because this fusion
activates the reporters by itself, in the absence of DE-cadherin.
Removing one or more repeats from repeats 3–8 eliminates
binding to DE-cadherin.
The Armadillo-binding Site on DE-cadherin Lies in a Small
Segment of the Cytoplasmic Domain—We used the two-hybrid
system to define the portion of DE-cadherin required for inter-
action with Arm. A series of constructs containing different
parts of the DE-cadherin cytoplasmic domain (Fig. 11A) were
tested for binding to the full repeat region of Arm. A 41-amino
acid fragment (amino acids 1426–1466, DEC6) is sufficient for
binding (Fig. 11B). A fragment consisting of amino acids 1350–
1446 (DEC3) showed substantial interaction, but a shorter
fragment (amino acids 1426–1446, DEC7) and all the frag-
ments beginning at amino acid 1447 (DEC8, DEC9, and
DEC10) did not interact with Arm.
DISCUSSION
Armadillo plays a central role in adherens junctions (3),
linking the transmembrane adhesive protein DE-cadherin to
a-catenin, which connects to the actin cytoskeleton. Depletion
of Arm disrupts cell adhesion and actin integrity and thus
disrupts organismal development (24, 42). We believe that Arm
is a linker, joining together other junctional proteins. To char-
acterize interactions between Arm and its junctional partners,
we defined the regions of Arm responsible for each interaction.
Both the sequence of Arm (the central two-thirds of the protein
is composed of ;13 imperfect 42-amino acid Arm repeats (9,
28)) and the results of previous genetic analysis of mutant Arm
proteins (3) suggested that Arm is modular in structure. We
thus hypothesized that one might be able to define specific
FIG. 5. Association of mutant Arm proteins with a-catenin or
DE-cadherin in vivo. A, armS10 mutant protein was immunoprecipi-
tated from embryo extracts (left lane) with anti-c-Myc antibody, and the
immunoprecipitate (IP) was analyzed by SDS-PAGE and immunoblot-
ting with anti-c-Myc, anti-a-catenin (anti a-cat), and anti-BicD antibod-
ies, respectively. B–D, embryo extract made from animals heterozygous
for one of a set of different arm mutant alleles was incubated with
ConA-Sepharose, which interacts with the DE-cadherin-catenin com-
plex. Bound and unbound protein fractions were separated by SDS-
PAGE and immunoblotted with anti-Arm antibody. Blots were reprobed
with antibody directed against the cytoplasmic protein BicD, which
should not bind cadherin, as a negative control. B, most ArmDN protein
is in the bound fraction. C and D, the C-terminally truncated mutant
protein encoded by armH8.6 is also found in the bound fraction. Mutant
proteins truncated in repeat 13 (armXM19), repeat 10 (armXP33), and
repeat 9 (arm#2) can also bind to ConA. Proteins derived from different
arm alleles are labeled on the right; molecular weight markers are on
the left. E, shown is a diagram of proteins derived from the armmutant
alleles used here. wt, wild type.
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regions of Arm responsible for interaction with individual pro-
tein partners.
To test this hypothesis, we used three different assays to
map the regions of Arm responsible for a-catenin and DE-
cadherin binding. We analyzed interactions in vitro using GST-
Arm fusion proteins, examined interactions in yeast using the
two-hybrid system, and determined requirements for interac-
tion with partners in vivo. Each system has its own inherent
advantages and limitations, and these balance each other, at
least in part. GST fusion proteins provide a simpler system by
purifying one component and permit rapid assays, allowing
FIG. 6. Point mutations inside the
76-amino acid region abolish a-cate-
nin binding. A, shown is the amino acid
sequence alignment of Arm family pro-
teins in the 76-amino acid a-catenin-bind-
ing region, using the one-letter code.
Identical residues are indicated with
lines, while similar residues are indicated
with colons. Residues altered in the dif-
ferent mutants are indicated above and
beneath the alignment. bcat, b-catenin;
plak, plakoglobin. B, wild-type and mu-
tant fusion proteins were assayed for
their ability to bind a-catenin using the
bead binding assay as described for Fig. 2.
Filters were subsequently immunoblotted
with anti-Arm antibody to compare load-
ing of the different fusion proteins (lower
panel). N2, the wild-type fragment con-
taining amino acids 25–165 of the N ter-
minus; N2-MX, mutant X in the wild-type
N2 fragment; CS, wild-type embryo ex-
tract (Canton S); GST, GST with no por-
tion of Arm attached;MMW, medium mo-
lecular weight markers.
FIG. 7. The N-terminal half of a-catenin binds to Arm. A, GST-
a-catenin fusion proteins were assayed for binding activity for Arm in
the bead binding assay as described for Fig. 2. Bound Arm was analyzed
by SDS-PAGE and immunoblotting with anti-Arm antibody (anti-BicD
antibody was used to control for nonspecific binding). a-cat, full-length
GST-a-catenin fusion protein; a-catRI, the N-terminal half of a-catenin.
B, the same blot was stained with Ponceau S to detect the amount of
fusion protein in each reaction. Full-length fusion proteins are indi-
cated with arrowheads. Molecular weight markers are on the left.
HMW, high molecular weight markers; MMW, medium molecular
weight markers; CS, wild-type embryo extract (Canton S).
FIG. 8. Mapping the region of Arm required for DE-cadherin
binding. A, wild-type embryo extract in NET was incubated with
GST-Arm fusion protein (diagramed in Tables I and II) bound to beads,
and bound proteins were analyzed by SDS-PAGE and immunoblotting
with anti-DE-cadherin antibody (upper panel). Anti-BicD antibody was
used as a control for nonspecific binding (lower panel). B, blots were
stained with Ponceau S to visualize the amount of fusion protein used
in each reaction. Arrowheads indicate the positions of full-length fusion
proteins. Molecular weight markers are indicated on the left. HMW,
high molecular weight markers; CS, wild-type embryo extract (Canton
S); R, Arm repeats.
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many proteins to be tested. However, this assay is performed
outside intact cells and involves the fusion of the protein of
interest to another protein. The yeast two-hybrid system meas-
ures interactions in an intact (although heterologous) cell, but
also involves the use of fusion proteins, and no components are
purified. Assaying interactions in vivo offers by far the most
realistic circumstances, but because of the investment in-
volved, one can assay only a small number of mutants.
All three assays agree on the essential results. A region of
Arm at the junction of the N terminus and the Arm repeats is
both necessary (in vitro, in yeast, and in flies) and sufficient (in
vitro and in yeast) for a-catenin binding, while the central-most
Arm repeats (repeats 3–8) are both necessary (in vitro, in
yeast, and in flies) and sufficient (in vitro and in yeast) for
DE-cadherin binding.
a-Catenin Binds to Armadillo at the Junction of the N Ter-
minus and the Arm Repeats—A 76-amino acid region at the
junction between the N terminus and the Arm repeats (amino
acids 90–165) is both necessary and sufficient for interaction
with a-catenin in vitro. Clustered point mutations throughout
the region reduce or abolish binding to a-catenin. Some or all of
these mutations may disrupt the structure of this part of Arm;
alternatively, mutated residues may reside on and thus disrupt
the interaction surface. Regardless, these results suggest that
the entire region is required to form either the folded structure
or the proper binding surface. Results from the yeast two-
hybrid assay were largely consistent with those from in vitro
binding assays (Fig. 4B).
One discrepancy was noted: in the two-hybrid system, a few
amino acids can be removed from the C terminus of this region
without eliminating a-catenin binding (amino acids 1–148, N5)
(Fig. 4A), while the same alteration blocks a-catenin binding in
the in vitro assay (Figs. 2 and 3). Perhaps the GST-N5 fusion
protein, as purified, lacks C-terminal amino acids due to pro-
teolysis. Our clustered point mutants suggest that amino acids
at or near the C terminus of this fusion protein are critical for
binding. Further mutational analysis, combined with struc-
tural studies, will help sort out which amino acids are critical
for forming an appropriately folded domain and which consti-
tute the actual surface involved in binding a-catenin.
We demonstrated the in vivo biological relevance of the in
vitro binding site (Fig. 5) (27). arm mutations deleting a region
N-terminal to the binding site (Fig. 5) or those deleting various
parts of the repeat region (27) do not affect interaction with
a-catenin in vivo, while in contrast, an arm mutant lacking 39
amino acids (amino acids 101–139) within the minimal in vitro
binding region blocks interaction with a-catenin in vivo (27).
This latter mutant is embryonic lethal and completely deficient
in adherens junction function (27).
Several studies examined the regions of the vertebrate rela-
tives of Arm, b-catenin and plakoglobin, required for a-catenin
binding (11–13, 15). These studies provide an excellent comple-
ment to our work. Comparison of these data with our own
reveals general agreement as to the site of binding, although
differences in the details may reveal subtleties of the in vivo
situation. Arm, b-catenin, and plakoglobin share substantial
amino acid sequence identity through the a-catenin-binding
region, and thus, these similarities are not surprising. The
most extensive previous study was that of Aberle et al. (15),
who analyzed the region of plakoglobin involved in a-catenin
binding. They found that amino acids 109–137 of plakoglobin
(Arm amino acids 125–154) are necessary and sufficient for
a-catenin binding (15); point mutations within this region iden-
tified amino acids critical to this interaction. In contrast, a
larger region of Arm is required for full a-catenin binding; 76
amino acids of Arm are required for strong interaction with
a-catenin (Figs. 2 and 3), while only 28 amino acids of plako-
globin are sufficient for binding (15). Our clustered point mu-
tants provide strong support for a more extended binding site.
Several mutations outside the minimal region defined by
Aberle et al. (15) block binding of a-catenin to Arm (Fig. 6).
Several possible explanations exist for these differences. First,
different assays are employed that may be more or less sensi-
tive. Second, our experiments may identify regions that pro-
mote but are not essential for binding. Third, and less likely
due to the sequence similarity between plakoglobin and Arm,
these proteins may genuinely differ in the details of a-catenin
binding.
We also obtained information about the region of a-catenin
required to bind Arm. The Arm-binding site on a-catenin maps
to its N-terminal third (Figs. 4 and 7). a-Catenin has three
blocks of sequence similarity to vinculin, VH1, VH2, and VH3
(43, 44); the Arm-binding site roughly corresponds to VH1,
while the actin-binding site of vinculin is found in the C-
terminal region near VH3 (43, 44).
The Central Repeats of Armadillo Bind to DE-cadherin—We
found that binding of Arm to DE-cadherin in vivo does not
require the N- or C terminus of Arm, but does require a signif-
TABLE II
Summary of Arm/cadherin interactions in the two-hybrid system.
A subset of the repeat region fragments tested for interaction with DE-cadherin (DE-cad) and mouse OB-cadherin (mOB-cad) are diagramed;
amino acids present in each construct are indicated. Binding activities are given as plus and minus symbols. R, Arm repeats.
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icant portion of the central Arm repeat region (Fig. 5) (27).
Examination of DE-cadherin binding in vitro and in yeast
allowed us to further narrow down the region required. A
fragment carrying Arm repeats 3–8 is the smallest piece of
Arm that interacts strongly with DE-cadherin. Removal of
single repeats (repeat 3, 5, or 8) from this minimal fragment
abolished interaction with DE-cadherin, although in the con-
text of longer Arm fragments, these particular Arm repeats
may not be essential for binding.
We confirmed the in vivo relevance of this binding site and
compared the effects of mutations in the repeat region both on
DE-cadherin binding in yeast and on DE-cadherin binding and
adherens junction function in flies. Our two-hybrid data are
largely consistent with the mutant phenotypes in vivo (27).
Mutations in repeat 1 or in repeats 10 and 11 (S6 and S12) do
not alter binding of Arm to DE-cadherin in yeast or in flies,
while deletion of repeats 3–6 eliminates binding both in yeast
and in flies. The one discrepancy involves the deletion of repeat
5 (S5), which reduces but does not eliminate DE-cadherin in-
teraction and adherens junction function in flies (27); in the
two-hybrid system, this mutation has little or no effect on
binding of repeats 1–13 to DE-cadherin. Perhaps the two-hy-
brid system, where interacting proteins are expressed at high
levels in a foreign environment, is less sensitive to reductions
in the affinity of the interaction.
Our results suggest two models for the nature of the cad-
herin-binding site on Arm: either it is partially redundant, or
the binding site is nonredundant, but must be presented in the
context of a minimum of six Arm repeats. Perhaps to form a
proper binding site and even for individual repeats to fold into
an appropriate tertiary structure, multiple repeats must fold
together into a higher order structure. All Arm repeat proteins
carry a block of six or more Arm repeats in tandem or near-
tandem arrays (9). The DE-cadherin-binding site may span
several repeats on the surface of a higher order structure, or it
may be localized to a single repeat, but only recognized in the
context of that higher order structure.
Our data complement and extend those obtained with the
vertebrate relatives of Arm (10–12, 45). All studies agree that
the central repeats are involved in binding. Plakoglobin trun-
cated after repeat 8 interacts with N-cadherin, whereas shorter
truncations progressively lose interaction (11). A plakoglobin
variant lacking repeat 4 shows reduced but detectable binding
to E-cadherin (12). In vivo deletion analysis of b-catenin impli-
cates the Arm repeats in E-cadherin binding; in one study,
interaction of E-cadherin with a b-catenin protein truncated
after repeat 10 was not observed (10), while in contrast, an
analogous truncation of Xenopus b-catenin binds C-cadherin in
vivo, whereas shorter fragments (repeats 1–9) do not (45).
These results are consistent with our in vivo results; armXP33
mutant protein, truncated in repeat 10, partially colocalizes
with DE-cadherin in vivo and retains a small amount of adhe-
FIG. 9. The central Arm repeats are required for DE-cadherin
binding in the two-hybrid system. Different portions of the Arm
repeat region (see Table II) were fused to LexA in pCK2 and assayed for
interaction with the cytoplasmic domain of DE-cadherin (DEC) or with
the cytoplasmic domain of mouse OB-cadherin (mOB-cad). The control
plasmid pCK4 encodes only the Gal4p transcriptional activation do-
main. Arm fragments named RX–Y include all of Arm repeats X
through Y; those ending after repeat 10 include the insert between
repeats 10 and 11. Some Arm constructs (such as repeats 1–13) activate
the lacZ reporter even with pCK4, but give substantially higher b-ga-
lactosidase levels when DE-cadherin is present. b-Galactosidase activ-
ities are in Miller units. The inset shows the data for repeats 1–6 and
repeats 7–13 at higher resolution.
FIG. 10. Some mutations in the central repeats abolish inter-
action between Arm and DE-cadherin. A, shown is a diagram of the
mutations tested and their effect on Arm structure. B, fragments car-
rying repeats 3–8 (R3–8) and repeats 1–13 (R1–13) of Arm and mutant
forms of each were fused to LexA and tested for interaction with
DE-cadherin (DEC) in the two-hybrid system. The plasmid pCK4 car-
ries only the transcriptional activation domain. Values are in Miller
units.
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rens junction function (24). Together, the data suggest that the
central Arm repeats (repeats 3–8) form the core cadherin-
binding site, although full interaction in vivo may require a
more extended region.
In contrast, 41 amino acids of the DE-cadherin cytoplasmic
domain are sufficient for Arm binding (Fig. 11). A similar
region of vertebrate cadherins is required for b-catenin inter-
action (14, 46–49); this region of mouse E-cadherin contains
eight serine residues, at least some of which are phosphoryl-
ated. Mutation of all eight serines to alanines blocks b-catenin
binding (49). Stappert and Kemler (49) have suggested that
serine phosphorylation may be required for b-catenin binding;
five of these serines are conserved in mouse OB-cadherin, and
four are also conserved in DE-cadherin (DE-cadherin has a
fifth serine, but its position is not strictly conserved) (Fig. 11C).
Interestingly, a similar serine cluster is found in the 20-amino
acid repeats of the adenomatous polyposis coli (ATP) tumor
suppressor protein (Fig. 11C) (50). Phosphorylation of the 20-
amino acid repeats by the Ser/Thr kinase glycogen synthase
kinase 3b regulates the affinity of ATP for b-catenin (51),
suggesting that part of the b-catenin binding determinant on
its target is phosphoserine or phosphothreonine.
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